CDKN2B-AS1 and neoplasm: In our study, lncRNA (SOX2OT and ANRIL) and tumor markers (CEA, CYFRA21‐1, and SCCA) were combined into a single diagnostic panel after a logistic regression analysis in the training and validation sets.